Compare Stocks: MNPR, MSTR, and SEZL

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
MNPR Monopar Therapeutics	$72.00 -0.9%	$83.52	$50.07 ▼ $124.82	$483.12M	1.62	203,191 shs	203,205 shs
MSTR Strategy	$111.62 -2.4%	$143.93	$81.81 ▼ $213.83	$47.14B	3.6	21.28 million shs	17.70 million shs
SEZL Sezzle	$154.60 0.0%	$124.91	$49.50 ▼ $195.71	$5.22B	6.59	686,256 shs	341,432 shs

Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
MNPR Monopar Therapeutics	+1.32%	+8.12%	+0.83%	-35.70%	-11.99%
MSTR Strategy	-6.49%	-11.52%	-24.82%	+22.97%	-49.06%
SEZL Sezzle	+1.32%	-0.21%	+18.93%	+19.94%	+169.98%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
MNPR Monopar Therapeutics	$72.00 -0.9%	$83.52	$50.07 ▼ $124.82	$483.12M	1.62	203,191 shs	203,205 shs
MSTR Strategy	$111.62 -2.4%	$143.93	$81.81 ▼ $213.83	$47.14B	3.6	21.28 million shs	17.70 million shs
SEZL Sezzle	$154.60 0.0%	$124.91	$49.50 ▼ $195.71	$5.22B	6.59	686,256 shs	341,432 shs

Don't Wait for the OpenAI IPO

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
MNPR Monopar Therapeutics	+1.32%	+8.12%	+0.83%	-35.70%	-11.99%
MSTR Strategy	-6.49%	-11.52%	-24.82%	+22.97%	-49.06%
SEZL Sezzle	+1.32%	-0.21%	+18.93%	+19.94%	+169.98%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
MNPR Monopar Therapeutics	2.67	Moderate Buy	$122.78	68.59% Upside
MSTR Strategy	2.88	Moderate Buy	$244.79	117.88% Upside
SEZL Sezzle	2.67	Moderate Buy	$160.33	4.30% Upside

Current Analyst Ratings Breakdown

Latest MNPR, MSTR, and SEZL Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
11/12/2026	MNPR Monopar Therapeutics	HC Wainwright Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Buy
11/12/2026	MNPR Monopar Therapeutics	BTIG Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Buy
11/12/2026	MNPR Monopar Therapeutics	Cantor Fitzgerald Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Neutral ➝ Overweight	$119.00
11/9/2026	MSTR Strategy	Cantor Fitzgerald Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Overweight	$208.00
11/5/2026	SEZL Sezzle	TD Cowen Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Buy	$160.00 ➝ $200.00
11/5/2026	SEZL Sezzle	Needham & Company LLC Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Buy	$172.00 ➝ $220.00
11/3/2026	MSTR Strategy	B. Riley Financial Subscribe to MarketBeat All Access to unlock brokerage rankings	Lower Price Target	Buy	$195.00 ➝ $180.00
11/2/2026	MSTR Strategy	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Sell (D)
11/2/2026	SEZL Sezzle	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Hold (C+)
10/30/2026	MSTR Strategy	HC Wainwright Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Buy	$250.00
10/30/2026	MSTR Strategy	BTIG Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Buy	$250.00

(Data available from 11/13/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
MNPR Monopar Therapeutics	N/A	N/A	N/A	N/A	$20.62 per share	N/A
MSTR Strategy	$495.08M	95.84	N/A	N/A	$131.27 per share	0.86
SEZL Sezzle	$450.28M	11.53	$3.84 per share	40.01	$8.22 per share	18.70

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
MNPR Monopar Therapeutics	-$13.72M	-$2.17	N/A	N/A	N/A	N/A	-13.08%	-12.79%	N/A
MSTR Strategy	-$3.85B	-$60.88	N/A	3.78	N/A	-2,760.33%	-32.71%	-22.25%	N/A
SEZL Sezzle	$133.13M	$5.23	29.48	21.29	N/A	31.39%	81.99%	40.12%	N/A

Latest MNPR, MSTR, and SEZL Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/12/2026	Q3 2026	MNPR Monopar Therapeutics	-$0.8231	-$0.72	+$0.1031	-$0.72	N/A	N/A
11/4/2026	Q3 2026	SEZL Sezzle	$1.28	$1.37	+$0.09	$1.38	$155.01 million	$166.50 million
10/29/2026	Q3 2026	MSTR Strategy	$20.19	$44.75	+$24.56	$44.75	$127.76 million	$125.43 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
MNPR Monopar Therapeutics	N/A	N/A	N/A	N/A	N/A
MSTR Strategy	N/A	N/A	N/A	N/A	N/A
SEZL Sezzle	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
MNPR Monopar Therapeutics	N/A	33.56	33.56
MSTR Strategy	0.10	4.04	4.04
SEZL Sezzle	0.37	4.21	4.21

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
MNPR Monopar Therapeutics	1.83%
MSTR Strategy	59.84%
SEZL Sezzle	2.02%

Insider Ownership

Company	Insider Ownership
MNPR Monopar Therapeutics	9.70%
MSTR Strategy	5.40%
SEZL Sezzle	43.90%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
MNPR Monopar Therapeutics	22	6.71 million	6.06 million	Not Optionable
MSTR Strategy	1,539	422.36 million	399.55 million	Optionable
SEZL Sezzle	201	33.78 million	18.95 million	Optionable

MNPR, MSTR, and SEZL Headlines

Recent News About These Companies

Why Sezzle Inc. (SEZL) is a Top Growth Stock for the Long-Term

November 12 at 10:46 AM | zacks.com

Sezzle Earnings Call Signals Strong Growth and 2027 Momentum

November 11 at 4:13 PM | theglobeandmail.com

Robinhood Markets vs. Sezzle: Which Financial Stock Is a Better Buy for 2027?

November 11 at 3:11 PM | fool.com

KBW Sticks to Its Hold Rating for Sezzle Inc. (SEZL)

November 11 at 11:13 AM | theglobeandmail.com

Sezzle Inc. 2026 Q3 - Results - Earnings Call Presentation

November 10 at 1:38 PM | seekingalpha.com

Sezzle Provides Investor Presentation on Operating Metrics

November 10 at 6:51 AM | tipranks.com

Why Sezzle Inc. (SEZL) is a top momentum stock for the long term

November 9, 2026 | msn.com

3 Reasons Why Growth Investors Shouldn't Overlook Sezzle Inc. (SEZL)

November 9, 2026 | zacks.com

Why Sezzle Inc. (SEZL) is a Top Momentum Stock for the Long-Term

November 9, 2026 | zacks.com

Sezzle Q3 Earnings Forecast Boosted by Northland Securities

November 9, 2026 | americanbankingnews.com

Sezzle Q3 Earnings Forecast Raised by Northland Securities

November 9, 2026 | marketbeat.com

Analysts Have Conflicting Sentiments on These Financial Companies: Sezzle Inc. (SEZL) and Swiss Re AG (OtherSSREF)

November 8, 2026 | theglobeandmail.com

Northland Securities Expects Increased Earnings for Sezzle

November 8, 2026 | americanbankingnews.com

Sezzle (NASDAQ:SEZL) Shares Gap Up After Earnings Beat

November 7, 2026 | americanbankingnews.com

The 5 most interesting analyst questions from Sezzle’s Q3 2026 earnings call

November 6, 2026 | msn.com

Northland Securities Forecasts Sezzle FY2026 Earnings

November 6, 2026 | marketbeat.com

Sezzle (SEZL) Jumped, But What Is Driving Attention Now?

November 5, 2026 | finance.yahoo.com

TD Cowen Forecasts Strong Price Appreciation for Sezzle (NASDAQ:SEZL) Stock

November 5, 2026 | marketbeat.com

Sezzle Stock Surges 27% on Strong Q3 Results and Raised 2026 Guidance

November 5, 2026 | kucoin.comK

Sezzle Stock Jumps 16% On Q3 Profit And Revenue Surge

November 5, 2026 | rttnews.com

Why Sezzle (SEZL) stock is up today

November 5, 2026 | msn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

MNPR, MSTR, and SEZL Company Descriptions

Monopar Therapeutics NASDAQ:MNPR

$72.00 -0.68 (-0.94%)

Closing price 04:00 PM Eastern

Extended Trading

$72.01 +0.01 (+0.01%)

As of 04:10 PM Eastern

Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. Its lead product candidate in development is Validive, a clonidine hydrochloride mucobuccal tablet that is in Phase 2b/3 clinical trial for the prevention of chemoradiotherapy induced severe oral mucositis in patients with oropharyngeal cancer. The company also engages in developing Camsirubicin, an analog of doxorubicin, which is in Phase 1b clinical trial for the treatment of advanced soft tissue sarcoma; MNPR-101, a urokinase plasminogen activator receptor targeted antibody for the treatment of various cancers; MNPR-101 RIT, a radioimmunotherapeutic based on MNPR-101 for the potential treatment of cancer and severe COVID-19; and MNPR-202, an analog of camsirubicin to treat doxorubicin-and camsirubicin-resistant cancers. Monopar Therapeutics Inc. has collaborations with the Grupo Español de Investigación en Sarcomas for the development of camsirubicin in patients with advanced soft tissue sarcoma; NorthStar Medical Radioisotopes, LLC to develop radio-immuno-therapeutics targeting severe COVID-19; and the Cancer Science Institute of Singapore to evaluate the activity of MNPR-202 and related analogs in various types of cancer. The company was founded in 2014 and is headquartered in Wilmette, Illinois.

Strategy NASDAQ:MSTR

$111.62 -2.79 (-2.44%)

Closing price 04:00 PM Eastern

Extended Trading

$110.15 -1.47 (-1.32%)

As of 04:32 PM Eastern

Strategy Incorporated, formerly known as MicroStrategy, provides artificial intelligence-powered enterprise analytics software and services in the United States, Europe, the Middle East, Africa, and internationally. It offers Strategy ONE, a platform that allows non-technical users to access novel and actionable insights for decision-making, and Strategy Cloud for Government, which provides always-on threat monitoring designed to meet the strict technical and regulatory standards of governments and financial institutions. The company also delivers Strategy Support, helping customers achieve system availability and usage goals through responsive troubleshooting; Strategy Consulting, offering architecture and implementation services; and Strategy Education, which includes free and paid learning options. In addition, the company is actively involved in Bitcoin development. The company offers its services through direct sales force and channel partners. It serves the U.S. government, state and local governments, and government agencies, as well as a range of industries, including retail, banking, technology, manufacturing, insurance, consulting, healthcare, telecommunications, and the public sector. The company was incorporated in 1989 and is headquartered in Tysons Corner, Virginia.

Sezzle NASDAQ:SEZL

$154.60 -0.07 (-0.05%)

Closing price 04:00 PM Eastern

Extended Trading

$151.53 -3.07 (-1.98%)

As of 04:32 PM Eastern

Sezzle Inc. operates as a technology-enabled payments company primarily in the United States and Canada. The company provides payment solution in-store and at online retail stores; and through proprietary payments solution that connects consumers with merchants. It also offers Sezzle Platform that provides a payments solution for consumers that extends credit at the point-of-sale allowing consumers to purchase and receive the ordered merchandise at the time of sale while paying in installments over time; Pay-in-Four, which allows consumers to pay a fourth of the purchase price up front and then another fourth of the purchase price every two weeks thereafter over a total of six weeks; Pay-in-Full that allows consumers to pay for the full value of their order up-front through the Sezzle Platform without the extension of credit; and Pay-in-Two and other alternative installment options, which allow consumer to pay half of the value of their order up-front and the second half in two weeks. In addition, the company provides Sezzle Virtual Card that allows consumers to access the Sezzle Platform in the form of close-end installment loans and shop with merchants that are not integrated with Sezzle; Sezzle Anywhere, a paid subscription service that allows consumers to use their Sezzle Virtual Card at any merchant online or in-store; Sezzle Premium, a paid subscription service that allows its consumers to access large, non-integrated premium merchants; and Sezzle Up, an opt-in feature of the Sezzle Platform. Further, it offers Long-Term Lending through collaboration with third-party lenders and Product Innovation. Sezzle Inc. was incorporated in 2016 and is headquartered in Minneapolis, Minnesota.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest MNPR, MSTR, and SEZL Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest MNPR, MSTR, and SEZL Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

MNPR, MSTR, and SEZL Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

MNPR, MSTR, and SEZL Company Descriptions

Monopar Therapeutics NASDAQ:MNPR

Strategy NASDAQ:MSTR

Sezzle NASDAQ:SEZL

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest MNPR, MSTR, and SEZL Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest MNPR, MSTR, and SEZL Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

MNPR, MSTR, and SEZL Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

MNPR, MSTR, and SEZL Company Descriptions

Monopar Therapeutics NASDAQ:MNPR

Strategy NASDAQ:MSTR

Sezzle NASDAQ:SEZL

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools